Literature DB >> 24953892

Bile acid nephropathy in a bodybuilder abusing an anabolic androgenic steroid.

Randy L Luciano1, Ekaterina Castano2, Gilbert Moeckel2, Mark A Perazella3.   

Abstract

Bile acid nephropathy, also known as cholemic nephrosis or nephropathy, is an entity that can be seen in patients with severe cholestatic liver disease. It typically is associated with acute kidney injury (AKI) with various forms of hepatic disease. Most often, patients with severe obstructive jaundice develop this lesion, which is thought to occur due to direct bile acid injury to tubular cells, as well as obstructing bile acid casts. Patients with end-stage liver disease also can develop AKI, in which case a more heterogeneous lesion occurs that includes hepatorenal syndrome and acute tubular injury/necrosis. In this circumstance, acute tubular injury develops from a combination of hemodynamic changes with some contribution from direct bile acid-related tubular toxicity and obstructive bile casts. We present a case of AKI due to bile acid nephropathy in a bodybuilder who developed severe cholestatic liver disease in the setting of anabolic androgenic steroid use.
Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bile acid nephropathy; acute kidney injury; cholestatic jaundice

Mesh:

Substances:

Year:  2014        PMID: 24953892     DOI: 10.1053/j.ajkd.2014.05.010

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  17 in total

Review 1.  Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.

Authors:  Eberhard Nieschlag; Elena Vorona
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

2.  Cholemic nephrosis (bile cast nephropathy) with severe liver dysfunction.

Authors:  Tanushri Mukherjee; Inam Danish Khan; Rena Guha; Tanmay Ganguly
Journal:  Med J Armed Forces India       Date:  2018-10-11

Review 3.  Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.

Authors:  Juan Carlos Q Velez; George Therapondos; Luis A Juncos
Journal:  Nat Rev Nephrol       Date:  2019-11-13       Impact factor: 28.314

4.  Bile Acids Are Important Contributors to AKI Associated with Liver Disease: CON.

Authors:  Andrew S Allegretti; Justin M Belcher
Journal:  Kidney360       Date:  2021-05-04

5.  Renal tubular injury in hyperbilirubinemia: Bile cast nephropathy.

Authors:  Xun Zhao; Ruiyao Huang; Philip Wong; Pierre-Oliver Fiset; Marc Deschênes
Journal:  Can Liver J       Date:  2021-08-09

Review 6.  Bile cast nephropathy: A case report and review of the literature.

Authors:  Jaymon Patel; Saqib Walayat; Nikhil Kalva; Sidney Palmer-Hill; Sonu Dhillon
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 7.  Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics.

Authors:  Miren García-Cortés; Mercedes Robles-Díaz; Aida Ortega-Alonso; Inmaculada Medina-Caliz; Raul J Andrade
Journal:  Int J Mol Sci       Date:  2016-04-09       Impact factor: 5.923

8.  Bile Cast Nephropathy in Patients with Acute Kidney Injury Due to Hepatorenal Syndrome: A Postmortem Kidney Biopsy Study.

Authors:  Suman Lata Nayak; Manoj Kumar; Chhagan Bihari; Archana Rastogi
Journal:  J Clin Transl Hepatol       Date:  2017-05-04

9.  Severe Cholestasis and Bile Acid Nephropathy From Anabolic Steroids Successfully Treated With Plasmapheresis.

Authors:  Avegail Flores; Rosemary Nustas; Hoang-Lan Nguyen; Robert S Rahimi
Journal:  ACG Case Rep J       Date:  2016-01-20

10.  Severe Cholestasis and Bile Cast Nephropathy Induced by Anabolic Steroids Successfully Treated with Plasma Exchange.

Authors:  Christelle El Khoury; Toni Sabbouh; Hussein Farhat; Antoine Ferzli
Journal:  Case Rep Med       Date:  2017-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.